deflazacort has been researched along with prednisone in 123 studies
| Studies (deflazacort) | Trials (deflazacort) | Recent Studies (post-2010) (deflazacort) | Studies (prednisone) | Trials (prednisone) | Recent Studies (post-2010) (prednisone) |
|---|---|---|---|---|---|
| 452 | 99 | 115 | 41,222 | 5,274 | 8,409 |
| Protein | Taxonomy | deflazacort (IC50) | prednisone (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Homo sapiens (human) | 1.146 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 1.146 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 1.146 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 1.146 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 1.146 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (20.33) | 18.7374 |
| 1990's | 38 (30.89) | 18.2507 |
| 2000's | 23 (18.70) | 29.6817 |
| 2010's | 30 (24.39) | 24.3611 |
| 2020's | 7 (5.69) | 2.80 |
| Authors | Studies |
|---|---|
| Caporali, R; Caprotti, M; Caprotti, P; Montecucco, C; Notario, A | 1 |
| Barreira, JC; Bogado, CE; Flores, D; Lázaro, A; Maldonado-Cocco, JA; Messina, OD; Redondo, G; Riopedre, AM; Sebastián, ON; Zanchetta, JR | 1 |
| Adami, S; Cominacini, L; Daví, MV; Francia, G; LoCascio, V; Olivieri, M; Rossi, L | 1 |
| Brandi, L; Daugaard, H; Egfjord, M; Lewin, E; Olgaard, K; Storm, T; van Wowern, N | 1 |
| Klausen, B; Olgaard, K; von Wowern, N | 1 |
| Barreira, JC; Messina, OD | 1 |
| Allen, R; Ansell, BM; David, J; Green, JR; Hesp, R; Loftus, J; Reeve, J; Reid, DM; Woo, PM; Wright, DJ | 1 |
| Coulton, L; de Broe, M; Doherty, SM; Galloway, J; Gray, RE; Kanis, JA | 1 |
| Aicardi, G; Coppo, R; Cordone, G; Cottafava, F; Di Battista, E; Gusmano, R; Imbimbo, B; Milani, S; Terragna, A; Vignolo, M | 1 |
| Fraioli, P; Rizzato, G | 1 |
| Bagnasco, M; Canonica, GW; Ciprandi, G; Scordamaglia, A | 1 |
| Bruno, A; Cavallo-Perin, P; Cesco, L; Imbimbo, B; Pagano, G | 1 |
| Imbimbo, B; Indiveri, F; Piccardo, C; Piovano, P; Scudeletti, M | 1 |
| Rizzato, G | 1 |
| Balsan, S; Bourdeau, A; Grimberg, R; Lenoir, G; Stéru, D | 1 |
| Egsmose, C; Jørgensen, S; Krogsgaard, MR; Lund, B | 1 |
| Borghi, VC; Cesar, FP; Luthold, WW; Okada, H; Wajchenberg, BL | 1 |
| Brentani, MM; Cesar, FP; Martins, VR; Wajchenberg, BL | 1 |
| Bruno, A; Cassader, M; Cavallo-Perin, P; Pagano, G | 1 |
| Avioli, LV; Gennari, C; Imbimbo, B; Russell, JE | 1 |
| Gennari, C; Imbimbo, B | 1 |
| Barabino, A; Grifoni, V; Imbimbo, B; Indiveri, F; Pende, D; Scudeletti, M | 1 |
| Bonifacio, V; Criscuolo, D; Fraioli, F; Isidori, A; Paolucci, D | 1 |
| Imbimbo, B; Porzio, F; Schiavetti, L; Tuzi, T | 1 |
| Borghi, VC; Gianella, D; Giurna Filho, A; Lerário, AC; Liberman, B; Malerbi, DA; Okada, H; Prestes Cesar, F; Torres de Toledo e Souza, I; Wajchenberg, BL | 1 |
| Avioli, LV; Bernini, M; Fusi, L; Gennari, C; Imbimbo, B; Montagnani, M; Nardi, P; Scala, C | 1 |
| Bruno, A; Cavallo-Perin, P; Dall'Omo, AM; Imbimbo, B; Lombardi, A; Ozello, A; Pagano, G | 1 |
| Bruno, A; Cassader, M; Cavallo-Perin, P; Dall'Omo, AM; Imbimbo, B; Lombardi, A; Ozzello, A; Pagano, G | 1 |
| Avioli, LV; Bernini, M; Gennari, C; Imbimbo, B; Montagnani, M; Nardi, P | 1 |
| Adami, S; Ballanti, P; Bonucci, E; Fuccella, L; Galvanini, G; Imbimbo, B; Lo Cascio, V; Tartarotti, D | 1 |
| Beresford, JN; Coulton, LA; Ebsworth, NM; Elford, P; Gallagher, JA; Gowen, M; McGuire, MK; Meats, JE; Poser, J; Wright, D | 1 |
| Hahn, BH; Hahn, TJ | 1 |
| Baran, DT; Hahn, TJ; Halstead, LR; Imbimbo, B; Strates, B | 1 |
| Cavallo Perin, P; Ferraris, GM; Imbimbo, B; Lombardi, A; Pagano, G | 1 |
| Criscuolo, D; De Laurentis, C; Malagnino, F; Mazzucconi, MG | 1 |
| Bosco, O; Contini, P; Filaci, G; Indiveri, F; Lanza, L; Peirano, L; Puppo, F; Scudeletti, M; Setti, M | 1 |
| De Fazio, P; Epis, R; Fregoni, V; Nalli, G; Perseghin, P | 1 |
| Adami, S; Beneton, MN; Bertoldo, F; Kanis, JA; Lo Cascio, V; Poggi, G; Zanolin, ME | 1 |
| Fike, RR; Hirata, H; Kasama, T; Sawai, Y | 1 |
| Coirini, H; De Nicola, AF; Flores, D; Gonzalez Deniselle, MC; Vega, MC | 1 |
| Eberhardt, R; Gross, W; Krüger, K; Reiter, W; Zwingers, T | 1 |
| Kimberly, RP | 1 |
| Bosco, O; Imbimbo, B; Indiveri, F; Iudice, A; Lanza, L; Mantovani, L; Puppo, F; Scudeletti, M | 1 |
| Gennari, C | 1 |
| Avioli, LV | 1 |
| Aicardi, G; Benso, L; Coppo, R; Cordone, G; Di Battista, E; Sardella, ML; Sernia, O; Terragna, A; Verrina, E; Vignolo, M | 1 |
| Ansell, BM; David, J; Hesp, R; Loftus, JK; Reeve, J; Woo, PM | 1 |
| Ferraris, JR; Pasqualini, T | 1 |
| Blanco, R; González-Gay, MA; Monte, R; Santiago, J | 1 |
| Carlin, MC; Ferraris, JR; Prigoshin, N; Ramirez, JA; Redal, M; Samaniego, MC; Tambutti, ML | 1 |
| Reitter, B | 1 |
| Criswell, LA; Kolluri, S; Nettleman, MD; Saag, KG; Sems, KM | 1 |
| Anderson, JE; McIntosh, LM; Poettcker, R | 1 |
| Anderson, JE; Mantsch, HH; Shaw, RA | 1 |
| Alvarado-Vega, AG; Alvarez-Amador, L; Arce-Salinas, CA; Diliz, HS; Zaragoza, RM; Zúñiga-Armendáriz, V | 1 |
| Han, DS; Kim, MS; Kim, SI; Kim, YS; Lee, HY; Lim, SK; Park, K | 1 |
| Hurtado García, JF; López Rico, JJ; Talavera Sánchez, J | 1 |
| Ballanti, P; Bertoldo, F; Bonucci, E; LoCascio, C; LoCascio, V; Milani, S; Zanolin, EM | 1 |
| Anderson, JE; Brière, KM; Granberg, KE; McIntosh, L | 1 |
| Casez, JP; Horber, FF; Jaeger, P; Lippuner, K | 1 |
| Kim, MS; Kim, SI; Kim, YS; Lim, SK; Moon, JI; Park, K | 1 |
| Blanch Sancho, JJ; Carmona Martín, M; Navarro López, V; Puras Tellaeche, A; Sáez Barcelona, JA | 1 |
| Filaci, G; Indiveri, F; Lanza, L; Monaco, E; Monetti, M; Puppo, F; Scudeletti, M | 1 |
| Domene, H; Ferraris, JR; Galich, AM; Jasper, H; Legal, S; Pasqualini, T; Pennisi, P; Sorroche, P | 1 |
| Angelini, C; Berardinelli, A; Bonifati, MD; Bonometto, P; Gorni, K; Lanzi, G; Orcesi, S; Ruzza, G | 1 |
| Craig, JC; Hodson, EM; Knight, JF; Willis, NS | 1 |
| Arce-Salinas, CA; de la Torre-Rendón, F; González-La Riviere, O; Hernández-Vásquez, R | 1 |
| Bruscas Izu, C; Medrano San Ildefonso, M; Simon, L | 1 |
| Belmatoug, N; Cacoub, P; Chemlal, K; Cohen, P; De Gennes, C; Khalifa, P; Piette, JC; Verdoncq, B; Wechsler, B; Ziza, JM | 1 |
| Escolar, DM; Scacheri, CG | 1 |
| Christopher, C; Wong, BL | 1 |
| Abbasciano, V; Calia, N; Ceccotti, P; Galeotti, R; Gualandi, M; Nielsen, I; Sartori, S; Trevisani, L | 1 |
| Devogelaer, JP; Gennari, C | 1 |
| Campbell, C; Jacob, P | 1 |
| Kuntzer, T; Manzur, AY; Pike, M; Swan, A | 1 |
| Biggar, D; Doherty, TJ; Mahoney, DJ; Rodriguez, C; Roy, BD; Tarnopolsky, MA; Vajsar, J | 1 |
| Ashwal, S; Baumbach, L; Connolly, A; Florence, J; Mathews, K; McDonald, C; Moxley, RT; Pandya, S; Sussman, M; Wade, C | 1 |
| Coaccioli, S; Giuliani, M; Pinoca, F; Puxeddu, A; Sabatini, C | 1 |
| Balaban, B; Carry, T; Clayton, GH; Matthews, DJ | 1 |
| Castellanos-Alvarado, EA; Flores-Marquez, MR; Garcia-Estrada, J; Gonzalez-Castañeda, RE; Gonzalez-Perez, O; Luquin, S; Ramos-Remus, C | 1 |
| Angelini, C; Bonifati, DM; Ermani, M; Hoffman, EP; Pegoraro, E; Witchel, SF | 1 |
| Carvalho, MS; Della Corte Peduto, M; Marie, SK; Parreira, SL; Reed, UC; Resende, MB | 1 |
| Henderson, SO; Liu, M | 1 |
| Canepa, C; Dieguez, S; Liern, M | 1 |
| Goecke, H; Labarca, E; Martínez, G; Santamarina, M; Tapia, H; Vega, J | 1 |
| Ander, BP; Apperson, M; Liao, I; Lit, L; Liu, DZ; Sharp, FR; Walker, WL; Wong, B; Xu, H | 1 |
| Campbell, K; Ciafaloni, E; Fox, DJ; Moxley, RT; Pandya, S | 1 |
| Dooley, JM; Esser, MJ; Gordon, KE; MacSween, J; Sheppard, KM | 1 |
| Abruzzese, C; Camplone, G; Carlesimo, M; Cortesi, G; De Marco, G; Mari, E; Narcisi, A; Orsini, D | 1 |
| Arellanes-Garcia, L; Cornejo-Ballesteros, H; Hernandez-Da Mota, SE; Melgoza-del-Angel, C; Recillas-Gispert, C; Sanchez-Gonzalez, R; Teran-Estrada, L | 1 |
| Armaroli, A; Cecconi, I; Cicognani, A; Ferlini, A; Franzoni, E; Gennari, M; Gnudi, S; Malaspina, E; Merlini, L; Talim, B | 1 |
| Beytía, Mde L; Kirschner, J; Vry, J | 1 |
| Angelini, C; Peterle, E | 1 |
| Collins, J; Cripe, LH; Hor, KN; Rose, SR; Rutter, MM; Sawnani, H; Sucharew, H; Wong, BL; Woo, JG | 1 |
| Cripe, L; King, E; Kinnett, K; Pratt, J; Sage, J; Spicer, R; Uzark, K; Varni, JW; Wong, B | 1 |
| Bushby, K; Connor, EM; Damsker, J; Hoffman, EP; McCall, JM; Nagaraju, K; Reeves, E | 1 |
| Battini, R; Bello, L; Berardinelli, A; Bertini, E; Bianco, F; Bonfiglio, S; Bruno, C; Cavallaro, F; Comi, GP; D'Ambrosio, P; D'Amico, A; De Sanctis, R; Doglio, L; Donati, MA; Frosini, S; Magri, F; Mazzone, ES; Mercuri, E; Messina, S; Mongini, T; Motta, MC; Napolitano, S; Pane, M; Pegoraro, E; Pini, A; Politano, L; Previtali, S; Rolle, E; Rossi, F; Sacchini, M; Scalise, R; Sormani, MP; Torrente, Y; Vasco, G; Viggiano, E; Vita, G | 1 |
| Brady, RC; Golekoh, MC; Horn, PS; Hu, S; Norman, AM; Wong, BL | 1 |
| Campbell, K; Flanigan, KM; Gomez, AM; Mendell, JR; Viollet, L; Walker, CM; Wang, W | 1 |
| Campbell, KA; Fox, DJ; Kim, S; Matthews, DJ; Valdez, R | 1 |
| Benson, DW; Fleck, RJ; Gao, Z; Hor, KN; Jefferies, JL; Mazur, W; Sticka, JJ; Tandon, A; Taylor, MD; Towbin, JA; Villa, CR; Wong, BL | 1 |
| Bello, L; Cnaan, A; Duong, T; Gordish-Dressman, H; Henricson, EK; Hoffman, EP; McDonald, CM; Morgenroth, LP | 1 |
| Ciafaloni, E; DiGuiseppi, C; James, K; Lamb, MM; Ouyang, L; Pandya, S; Weitzenkamp, D; West, NA; Yang, M | 1 |
| Brassington, R; Jichi, F; Kuntzer, T; Manzur, AY; Matthews, E | 1 |
| Goldstein, SL; Jefferies, JL; Kaddourah, A; Mathew, J; Ryan, TD; Villa, CR; Wong, BL | 1 |
| Cwik, V; Dubow, JS; Fehlings, DL; Florence, JM; Greenberg, CR; Griggs, RC; King, W; Kissel, JT; Mendell, JR; Meyer, JM; Miller, JP; Moxley, RT; Pandya, S; Pestronk, A; Vanasse, M | 1 |
| Jefferies, JL; McMahon, MA; Rutter, MM; Rybalsky, I; Sawnani, H; Shellenbarger, KC; Tian, C; Wong, BL | 1 |
| Baranello, G; Barohn, RJ; Brown, MW; Bryan Burnette, W; Bushby, K; Butterfield, RJ; Campbell, C; Childs, AM; Ciafaloni, E; Darras, BT; Eagle, M; Finkel, RS; Flanigan, KM; Griggs, RC; Guglieri, M; Hart, KA; Herr, BE; Hirtz, D; Horrocks, I; Howard, JF; Hughes, I; King, WM; Kirschner, J; Kuntz, NL; Mah, JK; Manzur, AY; Martens, WB; McColl, E; McDermott, MP; McDonald, CM; McMillan, HJ; Mongini, T; Morrison, L; Pegoraro, E; Roper, H; Schara, U; Shieh, PB; Spinty, S; Straub, V; Tawil, R; Thangarajh, M; Vita, G; von der Hagen, M; Wicklund, M; Wilichowski, E; Wilkinson, J; Willis, T | 1 |
| Angelini, C; Astrea, G; Balottin, U; Battini, R; Bello, L; Berardinelli, A; Brighina, E; Catteruccia, M; Civati, F; Colia, G; D'Amico, A; D'Angelo, MG; Gaiani, A; Lombardo, ME; Magliano, L; Messina, S; Motta, MC; Pane, M; Patalano, M; Politano, L; Ricci, G; Sagliocchi, A; Scalise, R; Scutifero, M; Semplicini, C; Sframeli, M; Vita, G; Zaccaro, A | 1 |
| Horn, PS; Rice, ML; Wong, B; Yang, MB | 1 |
| Darras, BT; Elfring, G; Jin, F; Mcdonald, CM; Mcintosh, J; Narayanan, S; Peltz, SW; Shieh, PB; Souza, M; Trifillis, P | 1 |
| Abutaleb, ARA; Anderson, AS; Carr, JC; Khan, SS; McNally, EM; Wilcox, JE | 1 |
| Arteaga-Henríquez, M; Campos-Cabrera, BL; Montans, J; Morán-Villaseñor, E; Torrelo, A | 1 |
| Amaddeo, A; Amin, R; Burrows, C; Darmahkasih, A; Fauroux, B; Gurbani, N; Horn, PS; Khirani, S; Pascoe, J; Rutter, MM; Rybalsky, I; Sawnani, H; Shellenbarger, KC; Simakajornboon, N; Tian, C; Wong, B | 1 |
| Mayer, OH | 1 |
| Flanigan, KM; Waldrop, MA | 1 |
| Cox, DA; Darras, BT; Elfring, G; Landry, J; McDonald, CM; McDonnell, E; Peltz, SW; Sajeev, G; Shieh, PB; Signorovitch, J; Souza, M; Yao, Z | 1 |
| Freimark, J; Marden, JR; Signorovitch, J; Tian, C; Wong, BL; Yao, Z | 1 |
| Agboola, F; Fluetsch, N; Lin, GA; Pearson, SD; Rind, DM; Walton, SM | 1 |
| Cecconi, I; Cordelli, DM; Dormi, A; Merlini, L; Parmeggiani, A | 1 |
| Akour, A; Al-Tammemi, AB; AlMuhaissen, SA; Alrawashdeh, MN; An, H; Anastasia, L; Apkon, S; Armstrong, WS; Ayala Izurieta, JE; Barnett, K; Bhowmick, S; Biniskos, N; Booka, E; Brown, JC; Buchanan, SW; Campbell, C; Camporeale, A; Cantos, VD; Cao, Z; Chakraborty, RD; Chaturvedi, V; Chen, C; Chen, G; Chen, Y; Chou, PT; Ciconte, G; Colasanti, JA; Collins, LF; Darras, BT; de Carvalho, RM; De Morais, DC; Delegido, J; Dodd, J; Doki, Y; Dunfield, K; Elfring, G; Feng, B; Ferry, VE; Galaviz, KI; García, VJ; Greven, M; Guo, J; Gutierrez, M; Hameed, S; Hippler, M; Huang, JW; Isaac, ME; Ishihara, R; Ishikawa, H; Ito, Y; Jacobson, A; Jalouqa, S; James, TD; Jara Santillán, CA; Jiang, K; Jordan, R; Kampf, JW; Kato, H; Kato, K; Katzmarzyk, PT; Kaviani, A; Kawachi, H; Kawakubo, H; Khansari Nejad, N; Kitagawa, Y; Kojima, T; Kono, K; Koplowitz, B; Kubo, Y; Kuribayashi, S; Lahiri, CD; Lei, H; Leighton, C; Li, J; Liu, G; Lombardi, M; Lu, Y; Luo, Y; Ma, P; Mafa-Attoye, T; Mahmoud, NN; Makhlina, M; Makino, T; Manguso, F; Mano, M; Manso, AP; Marconi, VC; Márquez, CO; Matsubara, H; Matsuda, S; McDonald, CM; Mecarocci, V; Metcalfe, GD; Micaglio, E; Miele, L; Mire, EF; Miyazaki, T; Moi, CT; Moore, CM; Moran, CA; Muto, M; Nemoto, K; Nguyen, ML; Nusair, MB; Ochoa, A; Owen, G; Oyama, T; Palma-Dibb, RG; Pappone, C; Parsons, JA; Pasqualotto, N; Peltz, SW; Pesco Koplowitz, L; Pica, S; Postiglione, WM; Qureshi, M; Rhodes, J; Saeki, H; Sakai, M; Santinelli, V; Santos, C; Shah, NS; Shanahan, JP; Shieh, PB; Sisti, JM; Smith, TW; Sohda, M; Song, Y; Spana, C; Sturla, F; Su, BK; Sumitani, J; Szabo, B; Szymczak, NK; Tabiś, W; Takeuchi, H; Tang, X; Thevathasan, NV; Toh, Y; Tondi, L; Trifillis, P; Tsushima, T; Van Wittenberghe, S; Vicedomini, G; Wang, H; Wang, K; Wang, S; Wang, W; Wang, X; Wang, Y; Wu, F; Wu, X; Yamaji, T; Yamamoto, K; Yamatsuji, T; Yang, L; Yang, S; Yang, WH; Yang, Y; Yoshida, M; Yu, B; Yuan, L; Zabaleta, J; Zhang, C; Zhang, H; Zhang, L; Zhang, X; Zhang, Z; Zheng, WQ; Zheng, YX; Zhou, H; Zhou, J; Zhou, N; Zhu, W | 1 |
| Cook, T; Miller, H; Wong, BL | 1 |
| Biggar, WD; McDonald, CM; Skalsky, A | 1 |
22 review(s) available for deflazacort and prednisone
| Article | Year |
|---|---|
Drugs and the immune response: knowledge and perspectives in allergology.
Topics: Anti-Inflammatory Agents; Antibody Formation; Cromolyn Sodium; Dexamethasone; Fenoterol; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Immune System; Lymphocyte Activation; Pirenzepine; Prednisone; Pregnenediones; Prostanoic Acids; T-Lymphocytes | 1989 |
Glucocorticoids, glucose metabolism and hypothalamic-pituitary-adrenal axis.
Topics: Addison Disease; Blood Glucose; Cushing Syndrome; Female; Glucocorticoids; Gluconeogenesis; Glucose; Glucose Tolerance Test; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Insulin; Liver; Lypressin; Male; Obesity; Pituitary-Adrenal System; Prednisone; Pregnenediones | 1984 |
Glucocorticoids.
Topics: Animals; Anti-Inflammatory Agents; Bone Density; Drug Administration Routes; Glucocorticoids; Humans; Mice; Prednisone; Pregnenediones; Rheumatic Diseases | 1994 |
Low-dose corticosteroids in rheumatoid arthritis. A meta-analysis of their moderate-term effectiveness.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Chloroquine; Dose-Response Relationship, Drug; Humans; Prednisone; Pregnenediones; Treatment Outcome | 1996 |
Corticosteroid therapy for nephrotic syndrome in children.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Glucocorticoids; Humans; Infant; Nephrotic Syndrome; Prednisone; Pregnenediones; Randomized Controlled Trials as Topic | 2000 |
Pharmacologic and genetic therapy for childhood muscular dystrophies.
Topics: Animals; Cell Transplantation; Child; Child, Preschool; Clinical Trials as Topic; Creatine; Cytoskeletal Proteins; Drug Administration Schedule; Dystrophin; Female; Gene Expression Regulation; Genetic Therapy; Genetic Vectors; Humans; Male; Membrane Proteins; Mice; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophies; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Protein Biosynthesis; Sarcolemma; Utrophin | 2001 |
Corticosteroids in Duchenne muscular dystrophy: a reappraisal.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Cushing Syndrome; Evidence-Based Medicine; Humans; Male; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Randomized Controlled Trials as Topic | 2002 |
Deflazacort for the treatment of Duchenne Dystrophy: a systematic review.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Humans; Immunosuppressive Agents; Male; Muscle Contraction; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Randomized Controlled Trials as Topic; Treatment Outcome; Weight Gain | 2003 |
Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
Topics: Adrenal Cortex Hormones; Glucocorticoids; Humans; Male; Muscular Dystrophy, Duchenne; Prednisolone; Prednisone; Pregnenediones; Randomized Controlled Trials as Topic; Walking | 2004 |
Myth: nephrolithiasis and medical expulsive therapy.
Topics: Adrenal Cortex Hormones; Adrenergic Antagonists; Calcium Channel Blockers; Humans; Nephrolithiasis; Nifedipine; Prednisone; Pregnenediones; Sulfonamides; Tamsulosin; Ureteral Calculi | 2007 |
Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management.
Topics: Child; Disease Progression; Drug Administration Schedule; Humans; Male; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Time Factors; Treatment Outcome | 2010 |
Drug treatment of Duchenne muscular dystrophy: available evidence and perspectives.
Topics: Aminoglycosides; Genetic Therapy; Glucocorticoids; Humans; Immunosuppressive Agents; Muscular Dystrophy, Duchenne; Myostatin; Oxadiazoles; Prednisone; Pregnenediones; Utrophin | 2012 |
Old and new therapeutic developments in steroid treatment in Duchenne muscular dystrophy.
Topics: Exercise Test; Glucocorticoids; Humans; Immunosuppressive Agents; Muscle Strength; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones | 2012 |
Novel approaches to corticosteroid treatment in Duchenne muscular dystrophy.
Topics: Drug Discovery; Glucocorticoids; Humans; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones | 2012 |
Corticosteroids for the treatment of Duchenne muscular dystrophy.
Topics: Adrenal Cortex Hormones; Glucocorticoids; Humans; Male; Muscle Strength; Muscular Dystrophy, Duchenne; Prednisolone; Prednisone; Pregnenediones; Quality of Life; Randomized Controlled Trials as Topic; Walking | 2016 |
Pulmonary function and clinical correlation in DMD.
Topics: Disease Progression; Glucocorticoids; Humans; Morpholinos; Muscular Dystrophy, Duchenne; Oxadiazoles; Prednisone; Pregnenediones; Respiratory Function Tests; Respiratory Insufficiency | 2019 |
Update in Duchenne and Becker muscular dystrophy.
Topics: Adrenal Cortex Hormones; Dystrophin; Exons; Genetic Therapy; Humans; Male; Muscular Dystrophy, Duchenne; Mutation; Prednisone; Pregnenediones | 2019 |
Deflazacort vs prednisone treatment for Duchenne muscular dystrophy: A meta-analysis of disease progression rates in recent multicenter clinical trials.
Topics: Anti-Inflammatory Agents; Child; Disease Progression; Humans; Male; Multicenter Studies as Topic; Muscular Dystrophy, Duchenne; Prednisolone; Prednisone; Pregnenediones; Randomized Controlled Trials as Topic; Treatment Outcome; Walking | 2020 |
The Effectiveness and Value of Deflazacort and Exon-Skipping Therapies for the Management of Duchenne Muscular Dystrophy.
Topics: Cost-Benefit Analysis; Dystrophin; Exons; Humans; Immunosuppressive Agents; Models, Economic; Morpholinos; Muscular Dystrophy, Duchenne; Oligonucleotides; Oligonucleotides, Antisense; Prednisone; Pregnenediones; Randomized Controlled Trials as Topic; Treatment Outcome | 2020 |
Topics: Adult; Alcohol Drinking; Ammonia; Animals; Anti-Inflammatory Agents; Area Under Curve; B-Lymphocytes; Black or African American; Bleaching Agents; Body Mass Index; Brugada Syndrome; Carbon; China; Climate Models; Codon, Nonsense; Cohort Studies; Colitis; Colon; COVID-19; Cytokines; Dental Enamel; Dextran Sulfate; Disease Models, Animal; Disease Outbreaks; Dogs; Electrocardiography; Escherichia coli; Esophageal Neoplasms; Female; Follow-Up Studies; Forests; Georgia; Glucosides; Healthy Volunteers; Heart Ventricles; Hesperidin; HIV Infections; Humans; Humidity; Hydrogen Peroxide; Incidence; Influenza, Human; Longitudinal Studies; Magnetic Resonance Imaging, Cine; Male; Melanocortins; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Middle Aged; Muscular Dystrophy, Duchenne; Naphthol AS D Esterase; Naphthols; Neoplasms; Nitrates; Nitrites; Nitrous Oxide; Obesity; Pandemics; Patient Outcome Assessment; Patient Satisfaction; Plants; Prednisolone; Prednisone; Pregnenediones; Proportional Hazards Models; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Rats; Receptor, Melanocortin, Type 1; Retrospective Studies; Risk Factors; SARS-CoV-2; Seasons; Soil; Stroke Volume; T-Lymphocytes; Telemedicine; Temperature; Tetralogy of Fallot; Tooth Bleaching; Tooth Bleaching Agents; Trees; Urea; White People | 2021 |
Prednisone and deflazacort in Duchenne muscular dystrophy: a patient perspective and plain language summary publication of the Cincinnati study.
Topics: Child; Humans; Inflammation; Language; Male; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Scoliosis | 2022 |
Comparing Deflazacort and Prednisone in Duchenne Muscular Dystrophy.
Topics: Humans; Muscular Dystrophy, Duchenne; Prednisolone; Prednisone; Pregnenediones; Prospective Studies | 2022 |
35 trial(s) available for deflazacort and prednisone
| Article | Year |
|---|---|
Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis.
Topics: Adult; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Bone and Bones; Bone Density; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Menopause; Prednisone; Pregnenediones | 1992 |
Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.
Topics: Absorptiometry, Photon; Anti-Inflammatory Agents; Blood Pressure; Bone Density; Calcium; Double-Blind Method; Forearm; Humans; Lumbar Vertebrae; Mandible; Nephrotic Syndrome; Osteoporosis; Prednisone; Pregnenediones; Urea | 1992 |
Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort.
Topics: Adolescent; Anti-Inflammatory Agents; Arthritis, Juvenile; Body Height; Body Weight; Bone Density; Child; Child, Preschool; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Prednisone; Pregnenediones | 1991 |
A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders.
Topics: Analysis of Variance; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Bone and Bones; Calcium; Chronic Disease; Double-Blind Method; Drug Evaluation; Female; Glucose; Humans; Hydrocortisone; Male; Middle Aged; Polymyalgia Rheumatica; Prednisone; Pregnenediones | 1991 |
Comparison of growth retarding effects induced by two different glucocorticoids in prepubertal sick children: an interim long-term analysis.
Topics: Age Determination by Skeleton; Body Height; Body Weight; Child; Child, Preschool; Connective Tissue Diseases; Female; Glomerulonephritis; Growth Disorders; Humans; Linear Models; Longitudinal Studies; Male; Prednisone; Pregnenediones; Puberty; Random Allocation | 1991 |
Glucose intolerance after short-term administration of corticosteroids in healthy subjects. Prednisone, deflazacort, and betamethasone.
Topics: Adult; Betamethasone; Blood Glucose; C-Peptide; Double-Blind Method; Female; Glucocorticoids; Glucose Tolerance Test; Humans; Insulin; Male; Prednisone; Pregnenediones; Reference Values | 1989 |
Establishment of the relative antiinflammatory potency of deflazacort and prednisone in polymyalgia rheumatica.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Prednisone; Pregnenediones; Random Allocation; Therapeutic Equivalency | 1987 |
Comparison of the subacute effects of a new glucocorticoid, deflazacort, and prednisone on the hypothalamic-pituitary-adrenal axis of normal subjects.
Topics: Adult; Blood Glucose; Circadian Rhythm; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Insulin; Lypressin; Pituitary-Adrenal System; Prednisone; Pregnenediones | 1986 |
Deflazacort vs prednisone. Effect on blood glucose control in insulin-treated diabetics.
Topics: Aged; Anti-Inflammatory Agents; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Humans; Male; Middle Aged; Prednisone; Pregnenediones; Random Allocation | 1987 |
Clinical equivalence of a new glucocorticoid, deflazacort and prednisone in rheumatoid arthritis and S.L.E. patients.
Topics: Adolescent; Adult; Arthritis, Rheumatoid; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Prednisone; Pregnenediones; Therapeutic Equivalency | 1984 |
Acute changes in urinary radiocalcium following glucocorticoids administration in man.
Topics: Adult; Aged; Bone Resorption; Calcium; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Isotope Labeling; Male; Middle Aged; Prednisone; Pregnenediones | 1984 |
Acute effect of prednisone and deflazacort on glucose tolerance in prediabetic subjects.
Topics: Adult; Blood Glucose; Fatty Acids, Nonesterified; Female; Glucocorticoids; Glucose Tolerance Test; Humans; Male; Prediabetic State; Prednisone; Pregnenediones | 1982 |
Acute effects of deflazacort and prednisone on rates of mineralization and bone formation.
Topics: Adult; Aged; Alkaline Phosphatase; Calcification, Physiologic; Female; Humans; Male; Middle Aged; Osteoblasts; Osteogenesis; Prednisone; Pregnenediones; Prospective Studies; Time Factors | 1995 |
Long-term therapy with the new glucocorticosteroid deflazacort in rheumatoid arthritis. Double-blind controlled randomized 12-months study against prednisone.
Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Body Weight; Cushing Syndrome; Double-Blind Method; Electrocardiography; Female; Hormones; Humans; Immunoglobulins; Male; Middle Aged; Prednisone; Pregnenediones | 1994 |
Comparison of two glucocorticoid preparations (deflazacort and prednisone) in the treatment of immune-mediated diseases.
Topics: Adult; Anti-Inflammatory Agents; Arthritis, Rheumatoid; CD4-CD8 Ratio; Double-Blind Method; Humans; Lupus Erythematosus, Systemic; Middle Aged; Prednisone; Pregnenediones; Remission Induction | 1993 |
Potency ratio--a brief synopsis.
Topics: Anti-Inflammatory Agents; Bone Density; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Prednisone; Pregnenediones; Treatment Outcome | 1993 |
Dose-dependent effects of deflazacort and prednisone on growth and skeletal maturation.
Topics: Age Determination by Skeleton; Anti-Inflammatory Agents; Body Height; Body Weight; Child; Child, Preschool; Connective Tissue Diseases; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Kidney Diseases; Male; Prednisone; Pregnenediones | 1993 |
Deflazacort in juvenile chronic arthritis.
Topics: Absorptiometry, Photon; Analysis of Variance; Anti-Inflammatory Agents; Arthritis, Juvenile; Bone Density; Child; Chronic Disease; Double-Blind Method; Humans; Lumbar Vertebrae; Prednisone; Pregnenediones; Weight Gain | 1993 |
Deflazacort vs. prednisone in Duchenne muscular dystrophy: trends of an ongoing study.
Topics: Alkaline Phosphatase; Anti-Inflammatory Agents; Body Weight; Child; Child, Preschool; Creatine Kinase; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Male; Muscle Contraction; Muscular Dystrophies; Neurology; Prednisone; Pregnenediones | 1995 |
Assessment of the quality of life in kidney transplant patients: a randomized, double-blind comparison of Deflazacort and prednisone.
Topics: Adolescent; Adult; Double-Blind Method; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisone; Pregnenediones; Quality of Life; Reproducibility of Results; Sickness Impact Profile | 1996 |
Post-transplantation diabetes is better controlled after conversion from prednisone to deflazacort: a prospective trial in renal transplants.
Topics: Adult; Blood Glucose; Body Weight; Diabetes Mellitus; Female; Glycated Hemoglobin; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Prednisone; Pregnenediones; Prospective Studies | 1997 |
A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: prednisone versus deflazacort.
Topics: Adult; Aged; Anti-Inflammatory Agents; Biopsy; Bone Density; Female; Glucocorticoids; Humans; Ilium; Longitudinal Studies; Male; Middle Aged; Osteoporosis; Prednisone; Pregnenediones; Prospective Studies | 1998 |
Effects of deflazacort versus prednisone on bone mass, body composition, and lipid profile: a randomized, double blind study in kidney transplant patients.
Topics: Body Composition; Bone Density; Carbohydrate Metabolism; Double-Blind Method; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Transplantation; Lipid Metabolism; Lumbosacral Region; Male; Middle Aged; Prednisone; Pregnenediones; Prospective Studies | 1998 |
Effect of deflazacort on bone mineral density in renal transplant recipients.
Topics: Amino Acids; Biomarkers; Bone Density; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Osteocalcin; Osteoporosis; Postoperative Complications; Prednisone; Pregnenediones | 1998 |
An open comparison of the diabetogenic effect of deflazacort and prednisone at a dosage ratio of 1.5 mg:1 mg.
Topics: Anti-Inflammatory Agents; Blood Glucose; Drug Administration Schedule; Female; Fructosamine; Glucocorticoids; Glycated Hemoglobin; Humans; Immunosuppressive Agents; Male; Middle Aged; Multivariate Analysis; Prednisone; Pregnenediones; Prospective Studies | 1999 |
Effect of deflazacort versus methylprednisone on growth, body composition, lipid profile, and bone mass after renal transplantation. The Deflazacort Study Group.
Topics: Body Composition; Bone Density; Child; Child Development; Female; Growth; Growth Substances; Humans; Immunosuppressive Agents; Kidney Transplantation; Leptin; Lipids; Postoperative Period; Prednisone; Pregnenediones | 2000 |
A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy.
Topics: Adolescent; Child; Child, Preschool; Double-Blind Method; Humans; Male; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones | 2000 |
Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bone Density; Bone Diseases, Metabolic; Calcium; Double-Blind Method; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Middle Aged; Multicenter Studies as Topic; Prednisone; Pregnenediones; Prospective Studies; Spinal Fractures; Treatment Outcome; Vitamin D | 2001 |
Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adolescent; Body Composition; Child; Collagen; Collagen Type I; Creatine; Creatinine; Cross-Over Studies; Deoxyguanosine; Drug Therapy, Combination; Hand Strength; Humans; Male; Methylhistidines; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Organ Size; Peptides; Prednisone; Pregnenediones; Respiratory Muscles; Spirometry; Treatment Outcome | 2004 |
[Recovery of total inmunoglobulin and immunoglobulin subclasses in nephrotic syndrome: deflazacort vs methylprednisone].
Topics: Child, Preschool; Cross-Over Studies; Humans; Immunoglobulin G; Infant; Nephrotic Syndrome; Prednisone; Pregnenediones; Single-Blind Method | 2008 |
Comparison of the immunogenicity of intramuscular versus subcutaneous administration of trivalent inactivated influenza vaccine in individuals with neuromuscular diseases.
Topics: Anti-Inflammatory Agents; Child; Child, Preschool; Drug Interactions; Female; Hemagglutination Inhibition Tests; Humans; Infant; Influenza Vaccines; Injections, Intramuscular; Injections, Subcutaneous; Male; Neuromuscular Diseases; Prednisone; Pregnenediones; Prospective Studies | 2013 |
Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Child; Child, Preschool; Follow-Up Studies; Glucocorticoids; Humans; Internationality; Male; Muscular Dystrophy, Duchenne; Prednisolone; Prednisone; Pregnenediones; Young Adult | 2015 |
Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy.
Topics: Adolescent; Anti-Inflammatory Agents; Body Weight; Child; Child, Preschool; Double-Blind Method; Humans; Least-Squares Analysis; Male; Motor Activity; Muscle Strength; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Treatment Outcome | 2016 |
Developing standardized corticosteroid treatment for Duchenne muscular dystrophy.
Topics: Child; Child, Preschool; Disability Evaluation; Double-Blind Method; Drug Administration Schedule; Heart Function Tests; Humans; Immunosuppressive Agents; Male; Muscle Strength; Muscular Dystrophy, Duchenne; Patient Satisfaction; Prednisone; Pregnenediones; Range of Motion, Articular; Research Design; Vital Capacity | 2017 |
Deflazacort versus prednisone/prednisolone for maintaining motor function and delaying loss of ambulation: A post HOC analysis from the ACT DMD trial.
Topics: Adolescent; Age Factors; Anti-Inflammatory Agents; Child; Double-Blind Method; Dystrophin; Female; Humans; Male; Muscular Dystrophy, Duchenne; Prednisolone; Prednisone; Pregnenediones; Walk Test; Walking | 2018 |
66 other study(ies) available for deflazacort and prednisone
| Article | Year |
|---|---|
Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids.
Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Bone and Bones; Bone Density; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Gonadal Steroid Hormones; Humans; Menopause; Middle Aged; Osteocalcin; Prednisone; Pregnenediones; Progesterone | 1992 |
Effect of deflazacort on growth hormone response to insulin tolerance test.
Topics: Adult; Aged; Anti-Inflammatory Agents; Blood Glucose; Female; Growth Hormone; Humans; Insulin; Male; Middle Aged; Prednisone; Pregnenediones | 1992 |
Steroid-induced mandibular bone loss in relation to marginal periodontal changes.
Topics: Adult; Alveolar Bone Loss; Anti-Inflammatory Agents; Bone Density; Bone Resorption; Dental Plaque; Female; Follow-Up Studies; Forearm; Gingival Hemorrhage; Humans; Male; Mandible; Mandibular Diseases; Middle Aged; Nephrotic Syndrome; Periodontal Diseases; Periodontal Pocket; Prednisone; Pregnenediones; Time Factors | 1992 |
Comment on the study of deflazacort versus prednisone in the treatment of chronic inflammatory disorders.
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Chronic Disease; Female; Humans; Inflammation; Prednisone; Pregnenediones | 1992 |
Natural and corticosteroid-induced osteoporosis in sarcoidosis: prevention, treatment, follow up and reversibility.
Topics: Anti-Inflammatory Agents; Calcitonin; Humans; Osteoporosis; Prednisone; Pregnenediones; Sarcoidosis | 1990 |
Effects of a new heterocyclic glucocorticoid, deflazacort (DFC), on the functions of lymphocytes from patients with rheumatoid arthritis (RA).
Topics: Arthritis, Rheumatoid; Female; Histocompatibility Antigens Class II; Humans; In Vitro Techniques; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Male; Middle Aged; Prednisone; Pregnenediones; T-Lymphocytes | 1987 |
Recent advances in sarcoidosis.
Topics: Anti-Inflammatory Agents; Bronchi; Clinical Enzyme Tests; Humans; Lung; Lung Diseases; Peptidyl-Dipeptidase A; Prednisone; Pregnenediones; Sarcoidosis; Therapeutic Irrigation | 1986 |
Effects of long-term maintenance therapy with a new glucocorticoid, deflazacort, on mineral metabolism and statural growth.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Body Height; Bone and Bones; Bone Diseases, Metabolic; Calcifediol; Calcium; Child; Child, Preschool; Female; Growth Disorders; Humans; Kidney Diseases; Male; Minerals; Parathyroid Hormone; Prednisone; Pregnenediones | 1987 |
Regulation of the glucocorticoid receptor by glucocorticoids in human mononuclear leukocytes.
Topics: Adolescent; Adrenal Cortex Diseases; Adult; Binding, Competitive; Female; Humans; Lymphocytes; Male; Middle Aged; Prednisone; Pregnenediones; Receptors, Glucocorticoid | 1986 |
Effects of deflazacort and the L-6485 metabolite on epiphyseal cartilage carbohydrate metabolism: comparison with prednisone.
Topics: Aerobiosis; Anaerobiosis; Animals; Cartilage, Articular; Epiphyses; Glucose; Glycolysis; In Vitro Techniques; Lactates; Male; Pentose Phosphate Pathway; Prednisone; Pregnenediones; Rats; Rats, Inbred Strains | 1985 |
Effects of prednisone and deflazacort on vertebral bone mass.
Topics: Anti-Inflammatory Agents; Double-Blind Method; Humans; Minerals; Osteolysis; Prednisone; Pregnenediones; Spine; Time Factors | 1985 |
Effect of single oral doses of prednisone and deflazacort on human lymphocyte distribution and functions. Analysis with monoclonal antibodies.
Topics: Adult; Antibodies, Monoclonal; Cells, Cultured; DNA; Histocompatibility Antigens Class II; Humans; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Prednisone; Pregnenediones; Rosette Formation; T-Lymphocytes; Thymidine | 1984 |
Effects of a new glucocorticoid, deflazacort, on pituitary-adrenal function in man: a comparison with prednisone.
Topics: Adrenocorticotropic Hormone; Adult; Blood Glucose; Female; Glucocorticoids; Humans; Hydrocortisone; Male; Pituitary-Adrenal System; Prednisone; Pregnenediones; Radioimmunoassay; Time Factors | 1980 |
Deflazacort versus prednisone diabetogenic effect evaluated by glucose clamp and compartmental analysis.
Topics: Adult; Blood Glucose; Humans; Insulin; Insulin Resistance; Insulin Secretion; Kinetics; Male; Prednisone; Pregnenediones | 1984 |
Comparison of acute and subacute effects of deflazacort and prednisone on glucose metabolism in man.
Topics: Adult; Anti-Inflammatory Agents; Blood Glucose; Drug Administration Schedule; Glucose; Humans; Insulin; Kinetics; Liver; Male; Prednisone; Pregnenediones | 1984 |
Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans.
Topics: Aged; Alkaline Phosphatase; Asthma; Bone and Bones; Bone Resorption; Calcium; Connective Tissue Diseases; Female; Humans; Male; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Phosphates; Prednisone; Pregnenediones | 1984 |
Bone loss after glucocorticoid therapy.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Osteoporosis; Prednisone; Pregnenediones; Time Factors | 1984 |
Effects of glucocorticoids and anabolic steroids on cells derived from human skeletal and articular tissues in vitro.
Topics: Alkaline Phosphatase; Animals; Bone and Bones; Bone Resorption; Cartilage, Articular; Cell Division; Cells, Cultured; Dexamethasone; Dihydroxycholecalciferols; Glucocorticoids; Humans; Mice; Monokines; Osteoblasts; Osteogenesis; Prednisone; Pregnenediones; Proteins; Stanozolol | 1984 |
Methods for reducing undesirable side effects of glucocorticoids.
Topics: Adult; Bone and Bones; Bone Resorption; Calcium; Female; Glucocorticoids; Humans; Hydrocortisone; Hydroxycholecalciferols; Lymphocytes; Male; Prednisone; Pregnenediones | 1984 |
Comparison of subacute effects of oxazacort and prednisone on mineral metabolism in man.
Topics: Adult; Bone and Bones; Calcium; Creatinine; Female; Humans; Hydrocortisone; Hydroxyproline; Male; Minerals; Oxazoles; Parathyroid Hormone; Prednisone; Pregnadienediols | 1980 |
Deflazacort in thrombocytopenia: a comparison with prednisone.
Topics: Adolescent; Adult; Female; Glucocorticoids; Humans; Male; Middle Aged; Platelet Count; Prednisone; Pregnenediones; Purpura, Thrombocytopenic | 1980 |
Interferons up-regulate with different potency HLA class I antigen expression in M14 human melanoma cell line. Possible interaction with glucocorticoid hormones.
Topics: Drug Synergism; Gene Expression; Glucocorticoids; Histocompatibility Antigens Class I; Humans; In Vitro Techniques; Interferons; Melanoma; Prednisone; Pregnenediones; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Up-Regulation | 1995 |
Churg-Strauss syndrome with peripheral polyneuropathy refractory to steroideal and immunosuppressive therapy successfully treated with plasma exchange.
Topics: Churg-Strauss Syndrome; Cyclophosphamide; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Middle Aged; Plasmapheresis; Polyneuropathies; Prednisone; Pregnenediones; Time Factors | 1995 |
Simultaneous determination of deflazacort metabolites II and III, cortisol, cortisone, prednisolone and prednisone in human serum by reversed-phase high-performance liquid chromatography.
Topics: Anti-Inflammatory Agents; Chromatography, High Pressure Liquid; Cortisone; Humans; Hydrocortisone; Prednisolone; Prednisone; Pregnenediones; Quality Control; Sensitivity and Specificity | 1994 |
Binding of the anti-inflammatory steroid deflazacort to glucocorticoid receptors in brain and peripheral tissues. In vivo and in vitro studies.
Topics: Animals; Anti-Inflammatory Agents; Binding, Competitive; Body Weight; Brain; Cerebral Cortex; Corticosterone; Dexamethasone; Hippocampus; In Vitro Techniques; Liver; Male; Methylprednisolone; Organ Size; Ornithine Decarboxylase; Pituitary Gland, Anterior; Prednisone; Pregnenediones; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Thymus Gland | 1994 |
Differential effect of glucocorticoids on calcium absorption and bone mass.
Topics: Adult; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Betamethasone; Bone Density; Bone Resorption; Calcium; Humans; Hypersensitivity; Intestinal Absorption; Male; Middle Aged; Prednisone; Pregnenediones; Sarcoidosis | 1993 |
Therapy with a new glucocorticoid: effect of deflazacort on linear growth and growth hormone secretion in renal transplantation.
Topics: Adolescent; Anti-Inflammatory Agents; Body Height; Child; Dose-Response Relationship, Drug; Female; Growth Hormone; Humans; Kidney Transplantation; Male; Prednisone; Pregnenediones; Radioimmunoassay; Time Factors | 1993 |
Low-dose corticosteroids and blindness in giant cell arteritis.
Topics: Aged; Anti-Inflammatory Agents; Blindness; Dose-Response Relationship, Drug; Giant Cell Arteritis; Humans; Male; Prednisone; Pregnenediones | 1996 |
Immunosuppressive activity of deflazacort in pediatric renal transplantation.
Topics: Adolescent; Adult; Cell Count; Child; Child, Preschool; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphocyte Culture Test, Mixed; Male; Postoperative Care; Prednisone; Pregnenediones; T-Lymphocytes, Cytotoxic | 1996 |
Deflazacort but not prednisone improves both muscle repair and fiber growth in diaphragm and limb muscle in vivo in the mdx dystrophic mouse.
Topics: Animals; Diaphragm; Leg; Mice; Mice, Inbred mdx; Muscle Fibers, Skeletal; Muscles; Muscular Dystrophy, Animal; Myositis; Prednisone; Pregnenediones; Regeneration; Wounds, Nonpenetrating | 1996 |
Infrared spectroscopy of dystrophic mdx mouse muscle tissue distinguishes among treatment groups.
Topics: Algorithms; Animals; Anti-Inflammatory Agents; Inflammation; Mice; Mice, Inbred mdx; Muscle, Skeletal; Muscular Dystrophy, Animal; Prednisone; Pregnenediones; Reproducibility of Results; Spectrophotometry, Infrared; Tendons | 1996 |
[Early corticoid treatment of idiopathic facial palsy (Bell)].
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Inflammatory Agents; Child; Clinical Protocols; Facial Paralysis; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Prednisone; Pregnenediones; Treatment Outcome | 1997 |
Nuclear magnetic resonance spectroscopy study of muscle growth, mdx dystrophy and glucocorticoid treatments: correlation with repair.
Topics: Animals; Discriminant Analysis; Linear Models; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Muscle Development; Muscle, Skeletal; Muscular Dystrophy, Animal; Phenotype; Prednisone; Pregnenediones; Regeneration | 1998 |
Possible differences in the mechanism(s) of action of different glucocorticoid hormone compounds.
Topics: Adult; Cytokines; Dexamethasone; DNA; Gene Expression; Glucocorticoids; Humans; Immunosuppressive Agents; NF-kappa B; Prednisone; Pregnenediones; T-Lymphocytes | 1999 |
Polyarteritis nodosa mimicking prostatic cancer.
Topics: Adenocarcinoma; Aged; Creatinine; Cyclophosphamide; Diagnosis, Differential; Humans; Hypertension; Immunosuppressive Agents; Male; Polyarteritis Nodosa; Prednisone; Pregnenediones; Prostate; Prostatic Neoplasms; Ultrasonography | 2000 |
[RS3PE syndrome: report of 11 cases].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Edema; Female; Humans; Male; Middle Aged; Polymyalgia Rheumatica; Prednisone; Pregnenediones; Syndrome; Synovitis | 2000 |
Sonographically guided biopsy and sonographic monitoring in the diagnosis and follow-up of 2 cases of sarcoidosis with hepatic nodules and inconclusive thoracic findings.
Topics: Anti-Inflammatory Agents; Biopsy, Needle; Female; Glucocorticoids; Humans; Liver Diseases; Middle Aged; Pleural Effusion; Prednisone; Pregnenediones; Sarcoidosis; Splenic Diseases; Tomography, X-Ray Computed; Ultrasonography | 2002 |
Deflazacort in giant cell arteritis.
Topics: Anti-Inflammatory Agents; Bone Density; Bone Diseases, Metabolic; Calcifediol; Dietary Supplements; Dose-Response Relationship, Drug; Giant Cell Arteritis; Humans; Prednisone; Pregnenediones; Randomized Controlled Trials as Topic | 2002 |
Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
Topics: Adolescent; Child; Child, Preschool; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Risk Assessment; Time; Weight Gain | 2005 |
[Study of lymphocyte subpopulations in chronic autoimmune inflammatory rheumatic diseases. II. Polymyalgia rheumatica: behaviour of lymphocyte subpopulations during treatment with two different corticosteroids].
Topics: Aged; Anti-Inflammatory Agents; CD4-CD8 Ratio; CD8-Positive T-Lymphocytes; Female; Humans; Immunosuppressive Agents; Lymphocyte Count; Male; Polymyalgia Rheumatica; Prednisone; Pregnenediones; Receptors, Antigen, T-Cell; T-Lymphocyte Subsets | 2005 |
Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect.
Topics: Adolescent; Anti-Inflammatory Agents; Body Height; Body Weight; Disease Progression; Dose-Response Relationship, Drug; Follow-Up Studies; Glucocorticoids; Humans; Male; Motor Activity; Motor Skills; Muscle Weakness; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Retrospective Studies; Statistics, Nonparametric | 2005 |
Deflazacort induced stronger immunosuppression than expected.
Topics: Animals; Astrocytes; Bacterial Infections; Dose-Response Relationship, Drug; Glucocorticoids; Immunosuppressive Agents; Male; Microglia; Neurons; Prednisone; Prefrontal Cortex; Pregnenediones; Rats; Rats, Wistar | 2007 |
The glucocorticoid receptor N363S polymorphism and steroid response in Duchenne dystrophy.
Topics: Anti-Inflammatory Agents; Child; Child, Preschool; Cohort Studies; Female; Humans; Male; Muscular Dystrophy, Duchenne; Polymerase Chain Reaction; Polymorphism, Genetic; Prednisone; Pregnenediones; Receptors, Glucocorticoid; Steroids | 2006 |
Quantification of muscle strength and motor ability in patients with Duchenne muscular dystrophy on steroid therapy.
Topics: Anti-Inflammatory Agents; Child; Child, Preschool; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Motor Activity; Muscle Strength; Muscle, Skeletal; Muscular Dystrophy, Duchenne; Prednisolone; Prednisone; Pregnenediones; Surveys and Questionnaires | 2007 |
Treatment of idiopathic retroperitoneal fibrosis with colchicine and steroids: a case series.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Colchicine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prednisone; Pregnenediones; Recurrence; Retroperitoneal Fibrosis; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Corticosteroid effects on blood gene expression in Duchenne muscular dystrophy.
Topics: Adipose Tissue; Adolescent; Case-Control Studies; Child; Child, Preschool; Chondroitin Sulfates; Gene Expression; Gene Expression Profiling; Humans; Iron; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Retrospective Studies; RNA, Messenger | 2009 |
Impact of bisphosphonates on survival for patients with Duchenne muscular dystrophy.
Topics: Adolescent; Adult; Child; Cohort Studies; Diphosphonates; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Retrospective Studies; Survival Analysis; Young Adult | 2011 |
An unusual case of annular bollous eruption of the inguinal folds.
Topics: Abdomen; Acantholysis; Adult; Anti-Inflammatory Agents; Axilla; Dermatitis Herpetiformis; Diagnosis, Differential; Eosinophilia; Female; Fluorescent Antibody Technique, Direct; Groin; Humans; Immunosuppressive Agents; Leg; Pemphigus; Prednisone; Pregnenediones | 2011 |
Lupus relapse presented as frosted branch retinal angiitis: case report.
Topics: Adolescent; Azathioprine; Female; Humans; Immunosuppressive Agents; Lupus Vasculitis, Central Nervous System; Methylprednisolone; Prednisone; Pregnenediones; Recurrence; Retinal Vasculitis; Treatment Outcome | 2011 |
Early corticosteroid treatment in 4 Duchenne muscular dystrophy patients: 14-year follow-up.
Topics: Adolescent; Adrenal Cortex Hormones; Follow-Up Studies; Humans; Longitudinal Studies; Male; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Prospective Studies; Puberty, Delayed; Stroke Volume; Treatment Outcome; Walking | 2012 |
Growth hormone treatment in boys with Duchenne muscular dystrophy and glucocorticoid-induced growth failure.
Topics: Body Height; Body Weight; Child; Glucocorticoids; Growth Disorders; Human Growth Hormone; Humans; Male; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Treatment Outcome | 2012 |
Health-related quality of life in children and adolescents with Duchenne muscular dystrophy.
Topics: Activities of Daily Living; Adolescent; Age Factors; Anti-Inflammatory Agents; Child; Child, Preschool; Disability Evaluation; Disease Progression; Humans; Male; Muscular Dystrophy, Duchenne; Needs Assessment; Prednisone; Pregnenediones; Quality of Life; Reference Values; Sick Role; Social Adjustment; Surveys and Questionnaires; Wheelchairs | 2012 |
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy.
Topics: Adolescent; Analysis of Variance; Anti-Inflammatory Agents; Child; Child, Preschool; Exercise Test; Glucocorticoids; Humans; Logistic Models; Longitudinal Studies; Male; Muscular Dystrophy, Duchenne; Outcome Assessment, Health Care; Prednisone; Pregnenediones; Risk Assessment; Risk Factors; Time Factors; Walking | 2013 |
Anti-dystrophin T cell responses in Duchenne muscular dystrophy: prevalence and a glucocorticoid treatment effect.
Topics: Age Factors; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Dependovirus; Dystrophin; Genetic Therapy; Glucocorticoids; Humans; Immunosuppressive Agents; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones | 2013 |
Corticosteroid Treatments in Males With Duchenne Muscular Dystrophy: Treatment Duration and Time to Loss of Ambulation.
Topics: Adrenal Cortex Hormones; Age of Onset; Child; Disease Progression; Follow-Up Studies; Humans; Longitudinal Studies; Male; Muscular Dystrophy, Duchenne; Neuromuscular Agents; Prednisone; Pregnenediones; Proportional Hazards Models; Time Factors; United States; Walking | 2015 |
Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy.
Topics: Adolescent; Adult; Age Factors; Child; Disease Progression; Fibrosis; Glucocorticoids; Heart; Humans; Magnetic Resonance Imaging; Male; Muscular Dystrophy, Duchenne; Myocardium; Prednisone; Pregnenediones; Retrospective Studies; Stroke Volume; Young Adult | 2015 |
Corticosteroid Treatment and Growth Patterns in Ambulatory Males with Duchenne Muscular Dystrophy.
Topics: Adolescent; Body Height; Body Mass Index; Body Weight; Case-Control Studies; Child; Child, Preschool; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Male; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones | 2016 |
Identifying evidence of cardio-renal syndrome in patients with Duchenne muscular dystrophy using cystatin C.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Biomarkers; Cardio-Renal Syndrome; Child; Cross-Sectional Studies; Cystatin C; Echocardiography; Glomerular Filtration Rate; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Retrospective Studies; Ventricular Function, Left; Young Adult | 2016 |
Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Glucocorticoid Treatment.
Topics: Adolescent; Age Factors; Child; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Exercise Therapy; Follow-Up Studies; Fractures, Bone; Glucocorticoids; Humans; Insulin Resistance; Long-Term Care; Male; Muscular Dystrophy, Duchenne; Osteoporosis; Patient Care Team; Prednisone; Pregnenediones; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Weight Gain | 2017 |
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions.
Topics: Adolescent; Age Factors; Bone Density Conservation Agents; Breathing Exercises; Cardiotonic Agents; Child; Combined Modality Therapy; Dietary Supplements; Disability Evaluation; Female; Glucocorticoids; Health Care Surveys; Humans; Italy; Male; Muscular Dystrophies; Physical Therapy Modalities; Prednisone; Pregnenediones; Respiration, Artificial; Time Factors | 2017 |
Cataract development associated with long-term glucocorticoid therapy in Duchenne muscular dystrophy patients.
Topics: Adolescent; Cataract; Cataract Extraction; Child; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Intraocular Pressure; Male; Muscular Dystrophy, Duchenne; Ocular Hypertension; Prednisone; Pregnenediones; Prevalence; Retrospective Studies; Time Factors; Tonometry, Ocular; Young Adult | 2018 |
Myocarditis in Duchenne Muscular Dystrophy After Changing Steroids.
Topics: Adolescent; Drug Substitution; Emergency Service, Hospital; Humans; Male; Muscular Dystrophy, Duchenne; Myocarditis; Prednisone; Pregnenediones; Steroids | 2018 |
Different presentations of linear IgA disease in a father and daughter.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Child, Preschool; Dapsone; Fathers; Female; Humans; Linear IgA Bullous Dermatosis; Male; Middle Aged; Prednisone; Pregnenediones | 2019 |
Comparison of Pulmonary Function Decline in Steroid-Treated and Steroid-Naïve Patients with Duchenne Muscular Dystrophy.
Topics: Adolescent; Child; Disease Progression; Glucocorticoids; Humans; Male; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Respiratory Function Tests; Retrospective Studies | 2019 |
Real-world outcomes of long-term prednisone and deflazacort use in patients with Duchenne muscular dystrophy: experience at a single, large care center.
Topics: Adolescent; Bone Density; Child; Child, Preschool; Humans; Male; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Retrospective Studies; Stroke Volume; Ventricular Function, Left; Walking | 2020 |
Quadriceps muscle strength in Duchenne muscular dystrophy and effect of corticosteroid treatment.
Topics: Adolescent; Age Factors; Anti-Inflammatory Agents; Child; Child, Preschool; Drug Administration Schedule; Glucocorticoids; Humans; Male; Muscle Strength; Muscle Strength Dynamometer; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Quadriceps Muscle; Walking; Young Adult | 2020 |